NCT06292923Phase 2Completed

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Study sponsor: Tiziana Life Sciences LTD · TLSA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-09-17Actual
Enrollment · participants54Actual
Source updated2026-11-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Sep 2026. After: 17 Sep 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 2 fields changed

Primary completion date changed

Before: Nov 2025. After: Sep 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview